Molecular Partners's total assets for Q4 2024 were CHF158.53M, an increase of 2.80% from the previous quarter. MOLN total liabilities were CHF16.89M for the fiscal quarter, a 9.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.